博士，教授、主任医师，博士生导师
地址：乌鲁木齐中路12号，复旦大学附属华山医院，上海 200040
电话：021-52888236 (办公室)，021-52888234 (实验室)
传真：021-52888236
邮箱：jieliu@fudan.edu.cn
1. Li, W., Zhang, X., Lu, X., You, L., Song, Y., Luo, Z., Zhang, J., Nie, J., Zheng, W., Xu, D., Wang, Y., Dong, Y., Yu, S., Hong, J., Shi, J., Hao, H., Luo, F., Hua, L., Wang, P., Qian, X., Yuan, F., Wei, L., Cui, M., Zhang, T., Liao, Q., Dai, M., Liu, Z., Chen, G., Meckel, K., Adhikari, S., Jia, G., Bissonnette, M.B., Zhang, X., Zhao, Y., Zhang, W., He, C., Liu, J. (2017). 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers. Cell Res 27, 1243-1257.
2. Luo, F., Qian, J., Yang, J., Deng, Y., Zheng, X., Liu, J., and Chu, Y. (2016). Bifunctional alphaHER2/CD3 RNA-engineered CART-like human T cells specifically eliminate HER2(+) gastric cancer. Cell Res 26, 850-853.
3. Zhang, Y., Liu, Y., Duan, J., Yan, H., Zhang, J., Zhang, H., Fan, Q., Luo, F., Yan, G., Qiao, K., and Liu, J. (2016). Hippocalcin-like 1 suppresses hepatocellular carcinoma progression by promoting p21 stabilization by activating the ERK1/2-MAPK pathway. Hepatology 63, 880-897.
4. Luo, Z., Yu, G., Lee, H.W., Li, L., Wang, L., Yang, D., Pan, Y., Ding, C., Qian, J., Wu, L., Chu, Y., Yi, J., Wang, X., Sun, Y., Jeong, L.S., Liu, J., and Jia, L. (2012). The Nedd8-activating enzyme inhibitor MLN4924 induces autophagy and apoptosis to suppress liver cancer cell growth. Cancer Res 72, 3360-3371.
5. Yang, D., Li, L., Liu, H., Wu, L., Luo, Z., Li, H., Zheng, S., Gao, H., Chu, Y., Sun, Y., Liu, J., and Jia, L. (2013). Induction of autophagy and senescence by knockdown of ROC1 E3 ubiquitin ligase to suppress the growth of liver cancer cells. Cell Death Differ 20, 235-247.
6. Zhang, Q., Hou, D., Luo, Z., Chen, P., Lv, B., Wu, L., Ma, Y., Chu, Y., Liu, H., Liu, F., Yu, S., Zhang, J., Yang, D., and Liu, J. (2015). The novel protective role of P27 in MLN4924-treated gastric cancer cells. Cell Death Dis 6, e1867.
7. Zhang, H.L., Wang, M.D., Zhou, X., Qin, C.J., Fu, G.B., Tang, L., Wu, H., Huang, S., Zhao, L.H., Zeng, M., Liu, J., Cao, D., Guo, L.N., Wang, H.Y., Yan, H.X., and Liu, J. (2017). Blocking preferential glucose uptake sensitizes liver tumor-initiating cells to glucose restriction and sorafenib treatment. Cancer lett 388, 1-11.
8. Yang, H., Shi, L., Wang, B.A., Liang, D., Zhong, C., Liu, W., Nie, Y., Liu, J., Zhao, J., Gao, X., Li, D., Xu, G.L., and Li, J. (2012). Generation of genetically modified mice by oocyte injection of androgenetic haploid embryonic stem cells. Cell 149, 605-617.
9. Deng, J., Liu, Y., Lee, H., Herrmann, A., Zhang, W., Zhang, C., Shen, S., Priceman, S.J., Kujawski, M., Pal, S.K., Raubitschek, A., Hoon, D.S., Forman, S., Figlin, R.A., Liu, J., Jove, R., and Yu, H. (2012). S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites. Cancer Cell 21, 642-654.
10. Li, F., He, X., Ye, D., Lin, Y., Yu, H., Yao, C., Huang, L., Zhang, J., Wang, F., Xu, S., Wu, X., Liu, L., Yang, C., Shi, J., He, X., Liu, J., Qu, Y., Guo, F., Zhao, J., Xu, W., and Zhao, S. (2015). NADP(+)-IDH Mutations Promote Hypersuccinylation that Impairs Mitochondria Respiration and Induces Apoptosis Resistance. Mol Cell 60, 661-675.
11. Lian, Z., Liu, J., Wu, M., Wang, H.Y., Arbuthnot, P., Kew, M., and Feitelson, M.A. (2007). Hepatitis B x antigen up-regulates vascular endothelial growth factor receptor 3 in hepatocarcinogenesis. Hepatology 45, 1390-1399.
12. Liu, J., and Fan, D.M. (2007). Hepatitis B in China. Lancet 369, 1582-1583.
13. Liu, J., Lian, Z., Han, S., Waye, M.M., Wang, H., Wu, M.C., Wu, K., Ding, J., Arbuthnot, P., Kew, M., Fan, D., and Feitelson, M.A. (2006). Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma. Oncogene 25, 1008-1017.
14. Liu, J., Han, S., Ding, J., Wu, K., Miao, J., and Fan, D. (2005). COX2-related multicentric mixed-type Castleman's disease in a young man. Nat Clin Pract Oncol 2, 370-375, 376.
